BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31633244)

  • 1. Primary glioblastoma transcriptome data analysis for screening survival-related genes.
    Yang Y; Yan R; Zhang L; Meng X; Sun W
    J Cell Biochem; 2020 Feb; 121(2):1901-1910. PubMed ID: 31633244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening prognosis-related genes in glioblastoma by microarray analysis.
    Wang H; Zhang Y; Zhang C; Tong X
    Anticancer Drugs; 2020 Feb; 31(2):150-157. PubMed ID: 31567312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
    Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
    Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
    Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
    Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
    Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational analysis and verification of molecular genetic targets for glioblastoma.
    Xue L; Liu H; Chen Y; Wei L; Hong J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma.
    Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y
    Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
    Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
    DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINGO1, C7orf31 and VEGFA are prognostic genes of primary glioblastoma: analysis of gene expression microarray.
    Liu S; Xu Y; Zhang S
    Neoplasma; 2018; 65(4):532-541. PubMed ID: 30064229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.